Search
Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the second quarter of 2023. If you would like to discuss...
On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...
The use of artificial intelligence (AI) to create works of art and inventions raises interesting legal challenges to the protection of intellectual property (IP). The plain language of the Copyright Act and Patent Act present obstacles to inventors and artists who may use or be AI systems. Recent...
Saul Ewing LLP, a full-service law firm with attorneys in 16 offices, today announced that The Bond Buyer recognized the Firm’s Public Finance Practice on its Northeast Midyear Review lists of the Top Five Bond Counsel for 2022. The Firm earned a number one ranking in Delaware and a number four...
Developers Secure $83 Million Construction Loan For 25-Story Mixed-Use Project In Downtown Hollywood Attorneys Luis Flores and Michael Denberg of Saul Ewing represented the developer in closing the transaction. “We are proud to be part of a development team that is focused on bringing new life to...